IPOs

Atea, riding interest in COVID-19 drugs, pulls off one of 2020's top biotech IPOs
BioPharma Dive
Fri, 10/30/20 - 10:30 am
Atea Pharmaceuticals
COVID-19
IPOs
small molecule drugs
RemeGen readies $514M IPO as HKEX adds jewel to the crown
Endpoints
Wed, 10/28/20 - 10:43 am
IPOs
HKEX
RemeGen
Hong Kong
A record number of biotechs are going public. Here's how they're performing.
BioPharma Dive
Mon, 10/26/20 - 11:10 pm
IPOs
biotech
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
Endpoints
Fri, 10/23/20 - 11:57 am
Foghorn Therapeutics
IPOs
NASDAQ
chromatin regulatory system
Eargo soars after announcing $141.3M IPO
Mass Device
Mon, 10/19/20 - 10:45 am
Eargo
IPOs
hearing devices
NASDAQ
devices
The two months in 1980 that shaped the future of biotech
Stat
Sat, 10/17/20 - 11:49 pm
Nobel Prizer
biotech
IPOs
DNA
Genenetech
Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M
Endpoints
Fri, 10/16/20 - 12:16 pm
IPOs
biotech
SPAC
Matthew Roden
Praxis Precision Medicines
Tarsus Pharmaceuticals
Aligos Therapeutics
Kiromic Biopharma
Tumeric Acquisition
It’s Raining Biotech SPACs!
Forbes
Thu, 10/15/20 - 11:07 am
biotech
SPAC
IPOs
Codiak lands on Wall Street in second shot at IPO, raises $83M
Endpoints
Thu, 10/15/20 - 10:59 am
Codiak Biosciences
IPOs
SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D
Xconomy
Mon, 10/12/20 - 06:06 pm
SQZ Biotech
cancer
oncology
cell therapy
IPOs
Roche
4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
BioSpace
Sat, 10/10/20 - 11:48 pm
IPOs
biotech
Kronos Bio
Shattuck
Spruce Biosciences
Aziyo
How hot is Hong Kong's biotech IPO market? Two biotechs just raised $800M total
Endpoints
Thu, 10/8/20 - 11:14 pm
Hong Kong
IPOs
Everest Medicines
Genor Biopharma
IPO Update: Codiak BioSciences Proposes IPO Terms
Seeking Alpha
Thu, 10/8/20 - 11:06 am
Codiak Biosciences
IPOs
exosomes
Kronos Bio sets terms for IPO, flirting with billion-dollar unicorn valuation
Endpoints
Mon, 10/5/20 - 11:50 am
IPOs
Kronos Bio
NASDAQ
Foghorn blows its klaxon, gunning for a $100M IPO hot on the heels of its Merck deal
Fierce Biotech
Mon, 10/5/20 - 10:58 am
Foghorn Therapeutics
IPOs
Merck
chromatin regulatory system
C4's Andrew Hirsch blows up IPO to $182M, while oncolytic virus upstart nabs $87M offering
Endpoints
Sun, 10/4/20 - 12:13 am
C4 Therapeutics
Oncorus
IPOs
oncolytic viruses
Another huge quarter for biotech flotations
EP Vantage
Fri, 10/2/20 - 12:52 pm
biotech
IPOs
AlloVir
Relay Therapeutics
Nykarta
Dyne Therapeutics
Annexon Biosciences
More biotechs test the third way to market
EP Vantage
Thu, 10/1/20 - 09:58 am
biotech
SPAC
IPOs
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
Xconomy
Mon, 09/28/20 - 10:27 pm
Praxis Precision Medicines
Aligos Therapeutics
Tarsus Therapeutics
IPOs
Aligos Therapeutics, developing several different hep B and NASH treatments, files for $100M IPO raise
Endpoints
Mon, 09/28/20 - 10:46 am
IPOs
Algios Therapeutics
NASH
chronic hepatits B

Pages